Celldex Therapeutics | CLDX - Ebit

Stock Price
33.65
Daily Change
1.24 3.83%
Monthly
8.03%
Yearly
111.10%
Q2 Forecast
30.13

Celldex Therapeutics reported $-87.15M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
Agenus USD 14.4M 19.26M Dec/2025
Amgen USD 3.96B 464M Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Celldex Therapeutics USD -87.15M 13.54M Dec/2025
Glaxosmithkline GBP 2.3B 1.46B Dec/2025
Nektar Therapeutics USD -19.09M 15.26M Dec/2025
Northwest Biotherapeutics USD -14.32M 822K Sep/2025
Pfizer USD 4.65B 71M Dec/2025
Rigel Pharmaceuticals USD 447K 1.52M Jun/2024
Roche Holding CHF 9.56B 2.1B Dec/2025